NCT00838747|Completed
Loading search results
Sponsor study identifier
observational
7
1 country
1
Study Start
September 2008
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
January 2011
Actual (reported)Study Completion
July 2011
Actual (reported)The folate receptor (FR) is a cell marker that is over expressed on the cell surface of certain cancers, this occurs most frequently in ovarian cancers. Some normal tissues also express the FR, however in these normal tissues the FR is usually located on the tissue surface that is inaccessible to circulating drugs. As such, drugs which target the FR may potentially be used to achieve anti-tumour efficacy whilst reducing toxicity to normal tissues. Therefore the ability to measure FR levels from different cancer types may help to select patients who are most likely to benefit from treatment with FR targeted therapies. One such drug BGC 945 is currently being tested in preclinical study at The Institute of Cancer Research
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
July 2011
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 2008
Date type not reportedThis date has not been verified as actual or estimated.
September 5, 2008
Actual (reported)February 6, 2009
Actual (reported)January 2011
Actual (reported)July 2011
Actual (reported)To measure the levels of folate receptor in blood samples obtained from patients with ovarian cancer and from healthy volunteers
1 year
Gynaecological Cancer
Patients with ovarian cancer and healthy volunteers
Royal Marsden NHS Foundation Trust
London, Sutton, SM2 5PT, United Kingdom
Stan Kaye, Professor
Royal Marsden NHS Foundation Trust
7 participants (actual enrollment reported by the registry).
First Submitted
September 5, 2008
First Posted
February 6, 2009
Study Start
September 2008
Date type not reportedThis date has not been verified as actual or estimated.
Single and Multiple Ascending Doses of AZD1981 in Japan
Contact the study team to confirm eligibility.
Primary Completion
January 2011
Actual (reported)Study Completion
July 2011
Actual (reported)Last Updated
May 26, 2016
Record last verified: 2016-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: